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SUMMARY. Implants prepared with polymer blends [poly (e-caprolactone)-poly(lactide), PCL-PLA] at
different rates were developed from microspheres. Approximately 19% of dexamethasone acetate was en-
capsulated into the microspheres, and it was not dependent on polymer characteristics. DSC studies sug-
gested that there is not any signal of interaction between the polymers and the drug and also no influence
of any residual solvent in the microspheres. Infrared analysis indicated the chemical stability of the drug
even in the blend matrix. The developed devices present low degradation rate. 34% and 21% of dexam-
ethasone acetate was released from PLA and PCL alone implants at 10 weeks, respectively. Intermediate
amounts were released from the devices prepared at different PLA-PCL ratios in such a way that the
higher the amount of PCL, the slower was the drug release. This study demonstrates that polymeric drug
delivery systems allowed to a prolonged release of dexamethasone acetate in vitro. 
